Genotype-Proteotype Linkage in the Wiskott-Aldrich Syndrome1
暂无分享,去创建一个
[1] G. Roberto Burgio,et al. The Wiskott-Aldrich syndrome , 1995, European Journal of Pediatrics.
[2] Silvia Giliani,et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. , 2004, Blood.
[3] E. Remold-O’Donnell,et al. Early deficit of lymphocytes in Wiskott–Aldrich syndrome: possible role of WASP in human lymphocyte maturation , 2004, Clinical and experimental immunology.
[4] Kohsuke Imai,et al. Clinical course of patients with WASP gene mutations. , 2004, Blood.
[5] F. Candotti,et al. High incidence of lymphomas in a subgroup of wiskott–aldrich syndrome patients , 2003, British journal of haematology.
[6] Michael J. Byrne,et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. , 2002, Molecular cell.
[7] W. Lim,et al. Structure of the N-WASP EVH1 Domain-WIP Complex Insight into the Molecular Basis of Wiskott-Aldrich Syndrome , 2002, Cell.
[8] Y. Sasahara,et al. Wiskott-Aldrich syndrome in a female. , 2002, Blood.
[9] Adrian J. Thrasher,et al. Wasp in immune-system organization and function , 2002, Nature Reviews Immunology.
[10] E. Remold-O’Donnell,et al. A novel protocol to identify mutations in patients with wiskott-Aldrich syndrome. , 2002, Blood cells, molecules & diseases.
[11] E. Remold-O’Donnell,et al. An Alu-mediated deletion at Xp11.23 leading to Wiskott-Aldrich syndrome , 2002, Human Genetics.
[12] L. Notarangelo,et al. Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. , 2002, Blood.
[13] J. Whisstock,et al. The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.
[14] J. V. Stone,et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. , 2001, Blood.
[15] M. Vihinen,et al. Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain , 2000, Journal of Molecular Medicine.
[16] M. Kirschner,et al. Mechanism of N-Wasp Activation by Cdc42 and Phosphatidylinositol 4,5-Bisphosphate , 2000, The Journal of cell biology.
[17] F. Frischknecht,et al. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization , 2000, Nature Cell Biology.
[18] Michael K. Rosen,et al. Autoinhibition and activation mechanisms of the Wiskott–Aldrich syndrome protein , 2000, Nature.
[19] A Shcherbina,et al. WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction. , 1999, Journal of immunology.
[20] A. Fischer,et al. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation. , 1999, Blood.
[21] W. Lim,et al. Structure of the Enabled/VASP Homology 1 Domain–Peptide Complex A Key Component in the Spatial Control of Actin Assembly , 1999, Cell.
[22] D. Nelson,et al. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. , 1999, Journal of immunology.
[23] T. Hagemann,et al. The identification and characterization of two promoters and the complete genomic sequence for the Wiskott-Aldrich syndrome gene. , 1999, Biochemical and biophysical research communications.
[24] B. Gebhardt,et al. The inherent quantitative capacity of the reverse transcription-polymerase chain reaction. , 1999, Analytical biochemistry.
[25] R. Rogers,et al. Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions. , 1999, American journal of respiratory cell and molecular biology.
[26] U. Francke,et al. Novel mutations in the Wiskott‐Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes , 1999, Human mutation.
[27] L. Maquat,et al. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. , 1998, Trends in biochemical sciences.
[28] Yoshimi Takai,et al. Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP , 1998, Nature.
[29] S. Kanner,et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. , 1997, Blood.
[30] F. Finkelman,et al. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. , 1997, Journal of immunology.
[31] K. Siminovitch,et al. Identification of WASP mutations, mutation hotspots and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndrome , 1996, Human Genetics.
[32] A. Meindl,et al. Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product , 1996, Human Genetics.
[33] O. Parolini,et al. High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. , 1995, Blood.
[34] R. Blaese,et al. Scanning of the Wiskott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. , 1995, Human molecular genetics.
[35] R. Blaese,et al. Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[36] K. Sullivan,et al. A multiinstitutional survey of the Wiskott-Aldrich syndrome. , 1994, The Journal of pediatrics.
[37] U. Francke,et al. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.
[38] D. Kenney. Wiskott‐Aldrich syndrome and related X‐linked thrombocytopenia , 1990 .
[39] P. Sharp,et al. Splicing of messenger RNA precursors. , 1987, Science.
[40] P. Sharp,et al. Splicing of messenger RNA precursors. , 1985, Harvey lectures.
[41] J. Mandel,et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). , 1980, The Journal of pediatrics.
[42] F. Oski,et al. Hereditary thrombocytopenia with an intrinsic platelet defect. , 1969, The New England journal of medicine.
[43] J. Wolff,et al. Wiskott-Aldrich syndrome: clinical, immunologic, and pathologic observations. , 1967, The Journal of pediatrics.